A Phase III Study on the Safety, Pharmacokinetics and Ef

Project: Research project

Project Details

Description

A Phase III Study on the Safety, Pharmacokinetics and Efficacy of Coagulation Factor Vlla (Recombinant) in Congenital Hemophilia A or B Patients with Inhibitors to Factor VIII or IX
StatusFinished
Effective start/end date6/1/145/31/18

Funding

  • REVO BIOLOGICS, INC.

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.